title: Mutations of aspartate 103 in the Hm2 receptor and alterations in receptor binding properties of muscarinic agonists.
abstract: Aspartate 103 (D103) in the third transmembrane domain of the Hm2 receptor was mutated to glutamate (D103E), asparagine (D103N), or alanine (D103A). As measured by [3H]-NMS, no significant binding was observed in D103A, while a 2-fold decrease in ligand affinity was seen in D103E and a 32-fold decrease in affinity was found in the D103N mutant. Examination of reference agonists showed greater loss of affinity in D103N than in D103E with the rank order of change being: L-607,207>carbachol>arecoline>pilocarpine>oxotremorine>McN-A-343. Of the novel 1-azabicyclo[2.2.1]-heptan-3-one oxime agonists examined, arylacetylene oximes showed little alteration in binding in either the D103E or D103N mutants, while the geometric isomers of several bicyclic aryl-ene-yne oximes showed significant changes in affinity, especially in the D103N mutant. Thus, overall size of the agonist and/or spatial orientation of the molecule within the binding pocket contribute to changes measured in binding.
authors: Parke-Davis Pharmaceutical Research, Ann Arbor, MI 48105, USA.
authors: R D
authors: RD
authors: Schwarz
authors: C J
authors: CJ
authors: Spencer
authors: J C
authors: JC
authors: Jaen
authors: T
authors: T
authors: Mirzadegan
authors: D
authors: D
authors: Moreland
authors: H
authors: H
authors: Tecle
authors: A J
authors: AJ
authors: Thomas
mesh_terms: D008455:(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride / Q000378:metabolism / Q000494:pharmacology; D000409:Alanine / Q000235:genetics; D019943:Amino Acid Substitution; D000818:Animals; D001115:Arecoline / Q000378:metabolism / Q000494:pharmacology; D001216:Asparagine / Q000235:genetics; D001224:Aspartic Acid / Q000235:genetics*; D019556:COS Cells; D002217:Carbachol / Q000378:metabolism / Q000494:pharmacology; D018721:Muscarinic Agonists / Q000378:metabolism* / Q000494:pharmacology; D016297:Mutagenesis, Site-Directed; D010095:Oxotremorine / Q000378:metabolism / Q000494:pharmacology; D010862:Pilocarpine / Q000378:metabolism / Q000494:pharmacology; D043585:Receptor, Muscarinic M2; D011976:Receptors, Muscarinic / Q000235:genetics / Q000378:metabolism*; D014162:Transfection
chemical_list: D018721:Muscarinic Agonists; D043585:Receptor, Muscarinic M2; D011976:Receptors, Muscarinic; D010862:Pilocarpine; D001224:Aspartic Acid; D001115:Arecoline; D008455:(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; D010095:Oxotremorine; D001216:Asparagine; D002217:Carbachol; D000409:Alanine